PhD training day, Sevilla
Overview
Chimeric antigen receptor (CAR) T cell therapy represents a major breakthrough in cancer care since their approval by the Food and Drug Administration in 2017 for the treatment of pediatric and young adult patients with relapsed or refractory acute lymphocytic leukemia. Several CAR T cell therapies have been developed afterwards, demonstrating unprecedented efficacy in patients with B-cell malignancies and multiple myeloma.
​
On this training day, participants will be able to acquire 360º vision between research, development and clinical application to the patient.
Venue
Hospital Virgen del Rocío
Instituto de Biomedicina de Sevilla
Viral production room, cell production room, cytometry, apheresis and molecular department.
Sevilla
Organiser
Elena de la Torre.
Juan-Antonio Perez-Simon
How to get to Sevilla
Registration
15 places available for student members of the society.
Free registration for student members of SETGYC.
Students will be selected from the following questionnaire and we will select the lucky 15. Please apply by 15 July and we will contact you by the beginning of August to confirm who has been selected.